immunotherapy (Traverse Biotech)

N/A

Report date: 2025/06/11 10:45:49

Base Information

Drug Nameimmunotherapy (Traverse Biotech)
Drug Alias NameNOD-2 checkpoint modulator (Traverse Biotech)
ClassificationOther
Mechanisms of ActionMacrophages stimulantsMonocyte stimulantsNucleotide-binding oligomerization domain-containing protein 2 modulators +[4] 
TargetsNucleotide-binding oligomerization domain-containing protein 2
Therapy Area/IndicationsOsteosarcomaNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTraverse Biotech Inc
China Registration ClassN/A

Develop Information

Active CompaniesTraverse Biotech Inc
Inactive CompaniesN/A
Active IndicationsOsteosarcoma
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A